Seon-Young Kim

The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients—a randomized trial

Mirang Kim, Jeong-Hwan Kim, Haiyoung Jung, 2023, Leukemia.